Advanced Neuroendocrine Tumors of Pancreatic Origin
1 clinical trials · Condition
◉ Watch Advanced Neuroendocrine Tumors of Pancreatic Origin
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors (NCT00510068) | Novartis Pharmaceuticals | 2007-07-01 |
Track Advanced Neuroendocrine Tumors of Pancreatic Origin automatically
Every clearance here is in the API, with alerts when new ones post.